Bioactive surface coating for preventing mechanical heart valve thrombosis.

Area of Science:

• Biomaterials science
• Cardiovascular engineering
• Medical coatings

Background:

• Severe valvular heart disease necessitates prosthetic heart valves.
• Mechanical valves offer durability but pose risks of thrombosis and bleeding due to anticoagulation.
• Anticoagulation impacts patient quality of life and necessitates regular monitoring.

Purpose of the Study:

• To develop a bioactive coating for mechanical heart valves.
• The coating aims to prevent thrombosis and enhance patient outcomes.
• Investigate a novel drug-releasing coating to mitigate mechanical valve complications.

Main Methods:

• A catechol-based approach created a drug-releasing multilayer coating for mechanical valves.
• Coated valves underwent hemodynamic testing, durability assessment, and in vitro antithrombotic evaluation.
• In vivo studies involved surgical implantation of coated valves in pigs.

Main Results:

• An antithrombotic coating with ticagrelor and minocycline was successfully developed.
• Coated valves demonstrated favorable hydrodynamic performance, durability, and hemocompatibility.
• In vivo tests showed significantly reduced valve thrombosis in nonanticoagulated pigs.

Conclusions:

• The developed coating effectively inhibits mechanical valve thrombosis.
• This innovation may reduce reliance on anticoagulation and lower revision surgery rates.
• The bioactive coating holds promise for improving the safety and efficacy of mechanical heart valves.